Methods for inducing a natural killer (NK) cell-mediated immune response and for increasing NK cell activity
AssigneeDendreon Corporation
InventorsNadeem Sheikh, Lori Jones
Life of this patent
Estimating the term…
Loading patent…
AssigneeDendreon Corporation
InventorsNadeem Sheikh, Lori Jones
Estimating the term…
This disclosure relates to methods of inducing a natural killer (NK) cell-mediated immune response and increasing NK activity in a mammal for the treatment of tumors and virus infections, comprising isolating peripheral blood mononuclear cells (PBMCs) from a subject, exposing them in vitro to a protein conjugate comprising granulocyte macrophage colony stimulating factor (GM-CSF) covalently linked to a soluble peptide antigen to activate the PBMCs, and administering the activated PBMCs to the subject. The method also relates to assessing NK cell activity of activated PBMCs to determine whether the subject has had a therapeutically effective response to the protein conjugate.
A method for detecting a cytotoxic NK cell-mediated immune response in a subject, comprising:
A method for determining whether a subject has had a therapeutically effective response to a protein conjugate, comprising,
Dependencies are inferred from the claim text.